The market will catch on soon! This is a huge validation of the strategy and I certainly agree with someone earlier about spinning off or trade sale in due course.
first there will be US and EU dist deals to extract max value. IMO we are Looking at $400m + for evolis Aline. (Yes that is a pluck).
The core CDY biz thou is the therapeutics and testing which is shaping up very well.
GLTA
Ann: Landmark Study- FGF5 Critical Regulator of Human Hair Growth, page-25
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable